🔗 Share this article

As the US continues making unprecedented changes to its vaccine recommendations, a particular individual has surfaced unexpectedly: Dr. Tracy Beth Høeg, an American of Danish descent sports physician and public health researcher who initially gained attention by expressing skepticism about Covid vaccinations during the global health crisis and has focused upon alleged fatalities after COVID-19 vaccination in her short tenure at the FDA.

Planned Overhauls to Childhood Immunization Program

Health officials were set to reveal radical changes to the childhood vaccination calendar in December, synchronizing the US with the Danish immunization schedule, it is understood – a significant shift that would put the US at odds with many the global community with insufficient data for improved outcomes. This reveal has been pushed back until the new year.

In place of the top vaccines chief, Dr. Høeg is set to address the audience at the meeting. She was newly appointed interim head of the FDA’s CDER, the fifth appointee to lead the office this calendar year.

A New Direction at the Agency

The acting appointment might represent a strengthened alliance between the pharmaceutical and biologics divisions as Høeg and Dr. Prasad strengthen their influence at the agency – and it suggests a greater focus upon dismantling long-standing vaccines at the FDA.

Høeg has frequently advocated for ending certain childhood shot schedules in the US to become more in line with Denmark, a nation with universal health coverage and a citizenry approximately the size of the state of Wisconsin.

To date public appearances, she has persisted in emphasizing on vaccines – traditionally the responsibility of Prasad, director of the FDA’s vaccine center – as opposed to medication approval.

Doubts Over Qualifications

Dr. Høeg has no obvious track record in medication creation, regulation or administrative roles, which has been typical for previous heads of the biologics center. She has been employed at the FDA as a top consultant to the FDA chief and the vaccine center since earlier this year.

“She appears not to have any of the qualifications” for running the drug-regulation department, stated a neurologist and psychiatrist. “She lacks experience running a randomized controlled trial. She has no expertise in running a sizeable institution. She has no expertise in drug approvals.”

Previous directors of the center would “be deeply familiar with legal statutes and the research of medication creation”, noted Dr. Janet Woodcock. “Frankly, she doesn’t have the kind of background that previous people who headed the center have had.”

CDER has an immense workload at the FDA, the former commissioner stated.

“The public just pays attention on the new drug program, but the generic drug division authorizes numerous off-brand pharmaceuticals. There’s a biologic copycat branch, non-prescription drug unit and more, and every single one have to be looked after,” Dr. Woodcock noted. “The area you overlook, that’s the thing that I always told people is going to bite you.”

Additionally, a major administrative element to the position, which oversees in excess of 5,000 personnel. “It’s a huge management job, if you do it right,” the former official added.

Response and Controversial Policies

When asked about concerns about Høeg’s qualifications and whether this appointment represents more teamwork among regulatory chiefs on vaccines, a press secretary stated that the “concerns are based on flawed premises”.

“Her resume aligns with the duties of her position,” the spokesperson said, noting the period Høeg spent counseling the agency head on “medication safety and regulatory science, including computational safety modeling and vaccine surveillance”.

In her interim role, Dr. Høeg inherits the agency head's controversial priority voucher program, a contentious one-day medication authorization process that reportedly worried her former heads. “By what process are these therapies being picked for this fast-track system? Who makes the choices?” Dr. Howard said. “There is a lot of confidentiality occurring at the FDA right now.”

Broadly speaking, he remarked, “the Food and Drug Administration looks to be trending towards laxer regulations of most medications, except for immunizations.”

Documented History on Vaccines

Concerning immunizations, Høeg has a clearer, if concerning, past, Howard have noted. She authored a analysis using unverified crowd-sourced reports to determine the rate of heart inflammation after Covid immunization. She consulted for the state of Florida top health official Joseph Ladapo, who reportedly have changed statistics to suggest COVID-19 vaccinations are riskier than they are.

Among her “wish list” for the new federal leadership encompassed changing regulations for recently developed shots and ending “non-essential” vaccines, she stated post-election on a online show. At the agency, Dr. Høeg has allegedly floated the idea of excluding young men from getting COVID-19 vaccines.

“She’s an thorough ideologue who starts off with her beliefs and tailors the evidence to accommodate the data in a extremely misleading, dishonest way,” Howard argued.

Consolidating Power and a “Revenge Tour”

Dr. Høeg aligned with fellow skeptics, {like|